Rare diseases are rare, but
rare disease patients are numerous

Caption : Accreditation = ;

• • NETHERLANDS
  • Utrecht
  • UTRECHT
  • 
  • Molecular diagnosis of Familial Primary Hyperparathyroidism (MEN1 gene)
  • UMC Utrecht - Universitair Medisch Centrum Utrecht
  • More information
• • UNITED KINGDOM
  • Oxfordshire
  • OXFORD
  • 
  • Molecular diagnosis of Hyperparathyroidism Jaw Tumour syndrome (HRPT2/CDC73 gene: mutation screening by sequencing)
  • The Churchill Hospital
  • More information
• • FRANCE
  • RHONE-ALPES
  • LYON
  • Molecular diagnosis of hyperparathyroidism, familial, primary (CDC73 gene)
  • CHRU Lyon - Hôpital Edouard Herriot
  • More information
• • FRANCE
  • ILE-DE-FRANCE
  • PARIS
  • Molecular diagnosis of hyperparathyroidism (CASR and CDC73 genes)
  • CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
  • More information
• • FRANCE
  • NORD-PAS-DE-CALAIS
  • LILLE
  • Molecular diagnosis of hyperparathyroidism, familial, primary (HRPT2 gene)
  • CHRU de Lille - Centre de biologie et pathologie
  • More information
• • SPAIN
  • País Vasco
  • SAN SEBASTIÁN
  • Molecular diagnosis of endocrine tumor (TMEM127, SDHD, SHCD, CDC73, SDHB, SDHAF2, VHL, MEN1, AIP genes / array-CGH)
  • Policlínica Gipúzcoa
  • More information
• • FRANCE
  • ILE-DE-FRANCE
  • PARIS
  • Molecular diagnosis of familial primary hyperparathyroidism (CDC73 gene)
  • CHU Paris Centre - Hôpital Cochin
  • More information
• • SWEDEN
  • Stockholms läns landsting
  • STOCKHOLM
  • Molecular diagnosis of isolated hyperparathyroidism familial and hyperparathyroidism jaw tumour syndrome (CDC73 gene)
  • Karolinska University Hospital - Solna
  • More information
• • DENMARK
  • Fyn
  • ODENSE
  • Molecular diagnosis of familial primary hyperparathyroidism (CDC73 gene sequencing)
  • Amplexa Genetics A/S
  • More information